Soleno Therapeutics, Inc. · NASDAQ:SLNO
Avoro Capital Advisors LLC's stake in Soleno Therapeutics, Inc. fell to 4.10% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Avoro Capital Advisors LLC's stake in Soleno Therapeutics, Inc. fell to 4.10%, 2,050,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 2,050,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 4.10% | 2,050,000 |
| Behzad Aghazadeh | 4.10% | 2,050,000 |
Source
Related
- Soleno Therapeutics, Inc.
- Avoro Capital Advisors LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Avoro Capital Advisors LLC · May 15, 2026
- Schedule 13G · Avoro Capital Advisors LLC · Feb 17, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026